Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insight Molecular Diagnostics (IMDX) Assets (2020 - 2025)

Historic Assets for Insight Molecular Diagnostics (IMDX) over the last 6 years, with Q3 2025 value amounting to $43.9 million.

  • Insight Molecular Diagnostics' Assets fell 3742.59% to $43.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $43.9 million, marking a year-over-year decrease of 3742.59%. This contributed to the annual value of $35.1 million for FY2024, which is 5315.79% down from last year.
  • According to the latest figures from Q3 2025, Insight Molecular Diagnostics' Assets is $43.9 million, which was down 3742.59% from $50.5 million recorded in Q2 2025.
  • In the past 5 years, Insight Molecular Diagnostics' Assets ranged from a high of $177.4 million in Q2 2021 and a low of $35.1 million during Q4 2024
  • For the 5-year period, Insight Molecular Diagnostics' Assets averaged around $99.3 million, with its median value being $81.6 million (2023).
  • As far as peak fluctuations go, Insight Molecular Diagnostics' Assets surged by 19136.84% in 2021, and later crashed by 5315.79% in 2024.
  • Over the past 5 years, Insight Molecular Diagnostics' Assets (Quarter) stood at $159.6 million in 2021, then tumbled by 37.27% to $100.1 million in 2022, then decreased by 25.18% to $74.9 million in 2023, then tumbled by 53.16% to $35.1 million in 2024, then grew by 25.24% to $43.9 million in 2025.
  • Its Assets stands at $43.9 million for Q3 2025, versus $50.5 million for Q2 2025 and $60.4 million for Q1 2025.